title: Glutamine inhibits the lowering effect of glucose on the level of phosphoenolpyruvate carboxykinase mRNA in isolated rat hepatocytes.
abstract: The expression of phosphoenolpyruvate carboxykinase (P-pyruvate CK) was shown to be decreased by hypoosmolarity and increased by glutamine in perfused liver from fed rats [Newsome, W. P., Warskulat, U., Noe, B., Wettstein, M., Stoll, B., Gerok, W. & Häussinger, D. (1994) Biochem, J. 304, 555-560]. This work was undertaken to specify the mechanisms of glutamine action, using isolated hepatocytes from rats that had been starved for 24 h. At low concentrations (up to 5 mM), glutamine elicited a decrease in the level of P-pyruvate CK mRNA through cell swelling and, at higher concentrations, an increase in the mRNA level was observed. Experiments with combinations of glucose and glutamine or glucose and various amino acids demonstrated that glutamine counteracted the inhibitory effect of glucose on P-pyruvate CK mRNA at a transcriptional, level, and strongly suggested that the amide group of glutamine was involved in this effect. The metabolism of glucose was required for the reinforcement of the apparent stimulatory effect of glutamine, as demonstrated by the use of various sugars. Glucosamine, but not mannosamine, increased the level of P-pyruvate CK mRNA, as did glucose plus glutamine. These results suggest that the pathway leading from glucosamine-6-phosphate production might be responsible, at least partly, for the effect observed on P-pyruvate CK mRNA.
authors.affiliation: Institut Fédératif de Recherches Multidisciplinaires sur les Peptides no. 23, U.F.R. Médecine-Pharmacie de Rouen, Saint Eticnne du Rouvray, France.
authors.forename: A
authors.initials: A
authors.lastname: Lavoinne
authors.forename: A
authors.initials: A
authors.lastname: Husson
authors.forename: M
authors.initials: M
authors.lastname: Quillard
authors.forename: A
authors.initials: A
authors.lastname: Chédeville
authors.forename: A
authors.initials: A
authors.lastname: Fairand
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D005944:Glucosamine / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism*; D005973:Glutamine / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology*; D008297:Male; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000235:genetics*; D051381:Rats; D017208:Rats, Wistar; D013329:Structure-Activity Relationship; D013997:Time Factors
chemical_list: D005973:Glutamine; D000242:Cyclic AMP; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D005947:Glucose; D005944:Glucosamine